MLX (gene) explained

Max-like protein X is a protein that in humans is encoded by the MLX gene.[1] [2]

Function

The product of this gene belongs to the family of basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factors. These factors form heterodimers with Mad proteins and play a role in proliferation, determination and differentiation. This gene product may act to diversify Mad family function by its restricted association with a subset of the Mad family of transcriptional repressors, namely Mad1 and Mad4. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.

Interactions

MLX (gene) has been shown to interact with MNT,[3] [4] MXD1[3] [4] and MLXIPL.[3]

MLX must dimerize with MondoA[5] or with MLXIPL (carbohydrate-responsive element-binding protein) to regulate target genes.[6]

Further reading

Notes and References

  1. Bjerknes M, Cheng H . TCFL4: a gene at 17q21.1 encoding a putative basic helix-loop-helix leucine-zipper transcription factor . Gene . 181 . 1–2 . 7–11 . November 1996 . 8973301 . 10.1016/S0378-1119(96)00376-9 .
  2. Web site: Entrez Gene: MLX MAX-like protein X.
  3. Cairo S, Merla G, Urbinati F, Ballabio A, Reymond A . WBSCR14, a gene mapping to the Williams--Beuren syndrome deleted region, is a new member of the Mlx transcription factor network . Human Molecular Genetics . 10 . 6 . 617–27 . March 2001 . 11230181 . 10.1093/hmg/10.6.617 . free .
  4. Meroni G, Cairo S, Merla G, Messali S, Brent R, Ballabio A, Reymond A . Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? . Oncogene . 19 . 29 . 3266–77 . July 2000 . 10918583 . 10.1038/sj.onc.1203634 . 17891130 .
  5. Kaadige MR, Yang J, Wilde BR, Ayer DE . MondoA-Mlx transcriptional activity is limited by mTOR-MondoA interaction . . 35 . 1 . 101–110 . 2015 . 10.1128/MCB.00636-14 . 4295369 . 25332233.
  6. Song Z, Yang H, Zhou L, Yang F . Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges. . 20 . 20 . E5132 . 2019 . 10.3390/ijms20205132 . 6829382 . 31623194 . free.